Congenital TTP occurs as a result of ADAMTS13 mutations, with the debut usually occurring in the first years of life, whereas acquired TTP is associated with autoantibodies against ADAMTS13 [9]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.